The global nebulizer market was valued at $1.1 billion in 2021 and it is expected to reach $2.4 billion at a CAGR of 7.3% between 2022 and 2032. The rapid rise is linked to the rising prevalence of chronic respiratory disorders, the expanding need for home medical equipment, and the growing elderly population. Chronic obstructive pulmonary disease (COPD), according to the Centers for Disease Control and Prevention, is the fourth most common cause of mortality in the United States.
The liquid medication is turned into a mist using a nebulizer, which is then inhaled through a mouthpiece or a mask. People who have asthma can also benefit from this information because nebulizers are occasionally used to provide asthma medications. You must use a small machine to ingest steroids using this technique. Your mucous membrane's inflammation is reduced by these steroids, enabling your body to start healing. Nebulizer treatments significantly reduce sputum production, chest tightness, and coughing, which makes it simpler for you to breathe. Since nebulized medications are deposited directly into the respiratory tract, larger drug concentrations in the bronchial tree and pulmonary bed can be achieved with fewer side effects than when using the systemic route. The medicines used in nebulizers benefit a child by making the mucus in the lungs easier to cough out and by relaxing the muscles in the airways, which allows more air to enter and exit the lungs. Inhaling the drug directly into the lungs has a better and quicker effect than taking it orally. Hence, these benefits and primary factors are driving the market for nebulizers globally.
Source: SAI Research
Additionally, a significant factor in the rise in the prevalence of respiratory disorders in North America is the rising intake of alcohol, tobacco, and ultra-processed goods, particularly sugar-sweetened beverages. Around the world, the COVID-19 pandemic has had a huge impact on millions of people. The healthcare sector has been forced to adopt emergency measures in response to the pandemic, racing to create both therapeutic and preventive strategies. During the forecast period, the worldwide nebulizers market is anticipated to expand at a moderate CAGR. The prevalence of respiratory illnesses and an aging population are two factors driving the growth of the worldwide nebulizer market. The adoption of portable nebulizers is another factor driving the market. Nebulization is a spraying technique; hence the main factor limiting the growth of this market is the dispersion and drug waste that occurs during delivery to the respiratory system. The availability of nebulizer alternatives also prevents expansion. The potential possibility for the expansion of this industry is created by emerging economies like those in Asia-Pacific. These major factors would drive the market in the upcoming years.
The market for nebulizers and respiratory equipment is very developed, and the jet sector dominates it because of its low price. As a result, a fierce competition is anticipated for additional nebulization devices. Additionally, it is difficult for new technologies or devices to take off in developed markets, especially given the complexity of several national regulatory and reimbursement systems that must be adhered to for both medications and devices. Additionally, it is difficult for new technologies or devices to take off in developed markets, especially given the complexity of several national regulatory and reimbursement systems that must be adhered to for both medications and devices.
The nebulizer market is anticipated to expand during the projected period as a result of the aging population and rising demand for home healthcare equipment. The market for nebulizers is predicted to expand further as a consequence of technological developments. On the other hand, throughout the projection period, it is anticipated that the market for nebulizers would expand due to the decrease in the number of medications utilized during nebulization. In the upcoming years, the market for nebulizers will have more potential to expand due to the rising demand for home healthcare equipment.
Based on type, the global nebulizer market is categorized into Jet, Mesh, and Ultrasonic. The jet nebulizer segment has dominated the market with significant growth and is projected to drive the market during the forecast period due to its benefits and low costs devices. Additionally, the simplicity of using nebulizers and their effective design for drug administration have elevated jet nebulizers to the top of the market over time. These nebulizers have the benefit of being inexpensive and requiring little effort from the patient to produce an aerosol. The solvent evaporating during nebulization reduces the volume provided and concentrates the aerosol due to the rapid gas flow through a jet nebulizer. On the other hand, the mesh nebulizer segment also accounted for most of the share in the upcoming years. Due to improved patient acceptance, rapid healing, mobility, and simplicity, the mesh nebulizer market is anticipated to expand further. Further aiding in market penetration is the growing commercial acceptability of mesh nebulizers due to precise drug administration to the lung and decreased residual quantities. When compared to jet nebulizers, mesh nebulizers offer more use, portability, and energy efficiency, as well as similar lung deposition.
In terms of end-user, the hospitals and clinics category is expected to create more growth opportunities for the nebulizer market than other segments. The primary source of revenue for the overall healthcare sector comes from hospitals, which are a crucial component of it. So many businesses make significant financial and marketing strategy investments to promote their goods and services in hospitals. However, the home healthcare category is also gaining more popularity in several emerging countries from both North America and Asia-Pacific regions. Some of the major market drivers for home healthcare devices are anticipated to include the expanding senior population, the high incidence of target diseases, and the growing demand to reduce healthcare spending. Home healthcare is a reasonably priced substitute for pricey hospital visits, which is anticipated to spur industry expansion.
Geographically, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Africa. Among these, North America holds most of the share of the global nebulizer market. Additionally, the region is also estimated to hold its dominant position in the future. Some of the major market drivers for home healthcare devices are anticipated to include the expanding senior population, the high incidence of target diseases, and the growing demand to reduce healthcare spending. Home healthcare is a reasonably priced substitute for pricey hospital visits, which is anticipated to spur industry expansion. Furthermore, this region's market is expanding every day as a result of ongoing technological innovation. Patients looking for more portable nebulizer devices that can be transferred conveniently in times of need for patients suffering from asthma and other airway or lung ailments are doing so because of the region's fast-paced lifestyle. On the other hand, the Asia-Pacific region is also anticipated to become the second-largest market over the forecast period. The use of nebulizer devices has increased throughout the Asia Pacific due to the rising incidence of chronic obstructive pulmonary disease, or COPD. Asthma and chronic bronchitis are two examples of lung conditions that can worsen slowly over time and are referred to as a chronic obstructive pulmonary disease.
According to the study, key players such as Allied Healthcare Products (U.S), Agilent Technologies (U.S), Aerogen Limited (Ireland), Briggs Medical Service (U.S), BD (U.S), Beurer (Germany), Ca-Mi (Italy), FeelLife Health (U.S), GF Health Products (U.S), Invacare (U.S), Medline Industries (U.S), PARI Medical Holding GmbH (Germany), OMRON (Japan), Phillips (Netherlands), Teleflex (U.S), Trudell Medical (Canada), among others are leading the global nebulizer market.
|Market Size in 2021
|US$ 1.1 Billion
|Market Volume Projection by 2032
|US$ 2.4 Billion
|Forecast Period 2022 to 2032 CAGR
|2019, 2020 and 2021
|2022 to 2032
By Type: Jet, Mesh & Ultrasonic
By End-User Type: Home Healthcare, Emergency Centers & Hospitals and Clinics
North America, Europe, Asia-Pacific, LAMEA
|Allied Healthcare Products (U.S), Agilent Technologies (U.S), Aerogen Limited (Ireland), Briggs Medical Service (U.S), BD (U.S), Beurer (Germany), Ca-Mi (Italy), FeelLife Health (U.S), GF Health Products (U.S), Invacare (U.S), Medline Industries (U.S), PARI Medical Holding GmbH (Germany), OMRON (Japan), Phillips (Netherlands), Teleflex (U.S), Trudell Medical (Canada), & Others
The Global Nebulizer Market – by Type:
The Global Nebulizer Market – by End-User Type:
The Global Nebulizer Market – by Regions: